Allovir Inc., which has struggled since late last December, will merge with privately held Kalaris Therapeutics Inc. to develop therapies for treating neovascular and exudative retinal diseases.

Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its ... a negative regulator of T cells, suppressing their activity against cancer cells, so when that brake ...

Dizal has submitted sunvozertinib’s new drug application (NDA) to the US Food and Drug Administration (FDA) aiming to secure ...

Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

A new BLA for datopotamab deruxtecan aims for FDA accelerated approval to treat EGFR-mutated NSCLC based on data from ...

Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI ... mutations to significantly impair dolutegravir antiviral activity. Dolutegravir is well tolerated with few treatment ...

But the doctors say pharmacies stopped filling their prescriptions for the drug — which the FDA approved in 1996 for human use to treat parasitic diseases caused by round worms and black flies — after ...

The Federal Food, Drug and Cosmetic Act, the law that requires manufactures to prove the safety of their products ... drugs available on market without FDA approval: 1. DESI Pending – DESI ...

Autolus Therapeutics’ chimeric antigen receptor (CAR) T-cell therapy obecabtagene autoleucel (Aucatzyl) received FDA approval for adults with B-cell precursor acute lymphoblastic leukemia (ALL). The ...

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...

Employers are predicting an increase of as much as 9 percent, on average, but are generally avoiding passing along much of that to their employees, industry groups say. One son couldn’t prevent ...